CAH
Cardinal Health, Inc.
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Cardinal Health (CAH) Stock: Buy, Sell, or Hold?
$277.45
+0.66 (+0.24%)
▲
5d:
+5.93%
30d:
+15.74%
90d:
+19.98%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect CAH Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (18%)
Quality Score
30/100
Position
EXTENDED
30-Day Fair Range
$238.01 – $262.98
Position: EXTENDED
Forward P/E & Valuation
23.0x
STRETCHED
vs 19.1x historical avg
Wall Street Target
$293.27
+5.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$246.99 / $286.29
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CAH shows conflicting indicators. Wait for confirmation before entering.
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Nov 9, 2026 at $274.29 · last confirmed Nov 11, 2026
Strength: 7.6/10
Get Alerted When CAH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$384.36
Based on 10.9% avg growth
INTRINSIC VALUE TODAY
$238.66
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CAH is currently trading at $277.45, which is considered extended relative to its 30-day fair value range of $238.01 to $262.98. From a valuation perspective, the stock is trading at a premium (Forward PE: 23.0) compared to its historical average (19.1). At these levels, the market is pricing in 6.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CAH is in a uptrend. Immediate support is located at $246.99, while resistance sits at $286.29.
Market Sentiment: CAH scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CAH is in a uptrend. Immediate support is located at $246.99, while resistance sits at $286.29.
Market Sentiment: CAH scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$238.01 -
$262.98
Company Quality Score
30/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
18.1%
Trading Range & Key Levels
30-Day Trading Range
$238.01 -
$262.98
Current vs Trading Range
EXTENDED
Support Level
$246.99
Resistance Level
$286.29
Current Trend
Uptrend
Technical data as of
Nov 11, 2026
Protect Your Profits
CAH is technically overbought (RSI 77). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range (+5.5% above its trading range)
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($293.27)
- NEUTRAL: Trading at premium valuation - market expects 6.3% growth which is achievable
- WARNING: Composite score 30/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
23.02
Wall Street Target
$293.27
(+5.7%)
Revenue Growth (YoY)
5.5%
Earnings Growth (YoY)
26.6%
Profit Margin
0.7%
Valuation Premium vs History
+6.3% premium
PE vs Historical
23.0 vs 19.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.3%
(market-implied from PE analysis)
1-Year Target
$294.93
(+6%)
2-Year Target
$313.51
(+13%)
3-Year Target
$333.26
(+20%)
3-Yr Target (if PE normalizes)
(PE: 23→19)
PE COMPRESSION
$276.56
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.0, Growth: 17.8%)
$453.97
(+64%)
Base:
(SPY PE: 19.9, Growth: 17.8%)
$391.72
(+41%)
Bear:
(PE: 16.9, Growth: 17.8%)
$332.96
(+20%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (36x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 35.81 | Current EPS (TTM): $7.73
Bull Case
$474.81
(+71%)
Analyst growth 55.9%, PE expands to 39.4
Base Case
$431.65
(+56%)
Market implied 55.9%, PE stable at 35.8
Bear Case
$188.22
(-32%)
Severe decline -20.0%, PE contracts to 30.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share CAH Analysis
Share this live CAH analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CAH)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Cardinal Health's Q1 revenue beat expectations, driving a new record high for the stock. Analysts raised price targets for Edwards Lifesciences following a strong Q3 report.
Key Retail Themes:
Positive earnings reports
Price target increases
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:11 PM ET
Data refreshes hourly during market hours. Next update: 9:11 PM
Data refreshes hourly during market hours. Next update: 9:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CAH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
16 analysts |
$1129 | 37 SELL |
|
HSIC
Henry Schein Inc |
BUY
16 analysts |
$97 | 49 HOLD |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$373 | 37 SELL |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 52 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 46 HOLD |
Advanced CAH Option Strategies
Professional options setups generated by AI based on today's CAH price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CAH Research Pages
